Chrysosplenol-D, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in TripleNegative Human Breast Cancer Cells
By Sophia J. Lang, Michael Schmiech, Susanne Hafner, Christian Paetz,Katharina Werner, Menna El Gaafary, Christoph Q. Schmidt, Tatiana Syrovets and Thomas Simmet
Identification of the Active Compounds and Significant Pathways of Artemisia Annua in the Treatment of Non-Small Cell Lung Carcinoma based on Network Pharmacology
By Shu Qiao Zhang, Hai Bo Xu
Nobel Prize for artemisinin brings phytotherapy into the spotlight
By Thomas Efferth, Susana Zacchino, Milen I. Georgiev, Liang Liu, Hildebert Wagner, Alexander Panossian
Retrospective study of small pet tumors treated with Artemisia annua and iron
By Mohamed E.M. Saeed, Elmar Breuer, Mohamed-Elamir F. Hegazy and Thomas Efferth
Cancer/Leishmania treatment with the ACT-WHO validated LupArte2.0 ® capsules/tablets
By Dr. med. vet. Elmar Breuer
Artemisinin–Second Career as Anticancer Drug?
By Professor Dr. Thomas Efferth (Johannes Gutenberg University, Institute of Pharmacy and Biochemistry, Department of Pharmaceutical Biology, Staudinger Weg 5, 55128 Mainz, Germany.)
Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia Annua
By Dr. med. vet. Elmar Breuer • Professor Dr. Thomas Efferth (Received: 25 February 2014 / Accepted: 1 April 2014 © The Author(s) 2014.)
Artemisia annua and artemisin effects against canine cancer
An oxidatively stressful situation: a case of Artemisia annua L.